LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases

Author： Xu Pei   Li Dabing   Tang Xiaotong   Bao Xiaohang   Huang Jing   Tang Yongping   Yang Yang   Xu Haiwei   Fan Xiaotang  

Publisher： Humana Press, Inc

ISSN： 0893-7648

Source： Molecular Neurobiology, Vol.48, Iss.3, 2013-12, pp. : 715-728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: Therapeutic Targets in Neurodegenerative Diseases)

By  

Current Enzyme Inhibition, Vol. 9, Iss. 1, 2013-01 ,pp. : 1-2

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics

By Pong Kevin  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 127-139

Informa Healthcare

Access to resources Recommend Favorite

It may be possible to delay the onset of neurodegenerative diseases with an immunosuppressive drug (rapamycin)

By Aso Ester  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1215-1219

Informa Healthcare

Access to resources Recommend Favorite

The potential of microRNAs as biofluid markers of neurodegenerative diseases – a systematic review

By Danborg Pia B.   Simonsen Anja H.   Waldemar Gunhild   Heegaard Niels H. H.  

Biomarkers, Vol. 19, Iss. 4, 2014-06 ,pp. : 259-268

Informa Healthcare

Access to resources Recommend Favorite

New therapeutic agents for the treatment of bone diseases

By Lipton Allan  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 817-832

Informa Healthcare

Access to resources Recommend Favorite